Filing Details
- Accession Number:
- 0001567619-22-021363
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-06 21:29:18
- Reporting Period:
- 2022-12-02
- Accepted Time:
- 2022-12-06 21:29:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1514980 | Brian Mueller | 105 Digital Drive Novato CA 94949 | Evp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-12-02 | 1,101 | $104.50 | 27,746 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-12-02 | 2,139 | $67.81 | 29,885 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-02 | 2,139 | $104.50 | 27,746 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-12-02 | 3,761 | $67.81 | 31,507 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-02 | 3,761 | $104.50 | 27,746 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2022-12-02 | 2,139 | $0.00 | 2,139 | $67.81 |
| Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2022-12-02 | 3,761 | $0.00 | 3,761 | $67.81 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-11-15 | 2023-05-14 | No | 4 | M | Direct |
| 0 | 2013-11-15 | 2023-05-14 | No | 4 | M | Direct |
Footnotes
- Trade made pursuant to a 10b5-1 plan executed on March 14, 2022.
- Reflects the number of options outstanding after the transactions from this specific stock option grant.
Billionaire Hedge Funds
